You can’t just wish away stubborn body fat with pure discipline. If you’ve ever tried a restrictive diet, you’ve lived this exact scenario. You crush a morning workout, obsessively count the macros in your salad, and think you’re perfectly on track. Then your metabolism chimes in, and barely an hour later, you are completely famished all over again. That isn’t a failure of discipline. It’s just basic human biology.
That’s the exact gap that incretin medications are designed to fill. These drugs basically rewire the signals that your stomach communicates to your brain. If you’re up late frantically Googling “tirzepatide near me” and trying to figure out your next step, you need straight answers. In this article, we’ll walk you through what these shots actually do to your system, the physical side effects to watch out for, and what recent clinical studies are showing.
How Semaglutide Works
Semaglutide is a weekly shot under the skin. It copies GLP-1, the hormone that tells your brain you’ve eaten enough, and it affects your body in three ways.
- Slower digestion for longer satiety
- Quieter hunger cues in the brain
- Less mental focus on food
- Steady insulin release for balanced blood sugar
How Tirzepatide Differs
Unlike single-pathway options like semaglutide, tirzepatide hits two targets. It copies the effects of GLP-1 while activating GIP receptors in the gut.
The two hormones play different roles:
• GLP-1: Lowers appetite, slows digestion
• GIP: Targets fat processing, boosts insulin sensitivity
• Combined action: Stronger signaling, better carb and fat processing
This pairing likely helps explain why tirzepatide users lost more in trials. In SURMOUNT-1, people on the highest dose lost an average of about 21% to 22.5% of their weight over 72 weeks. At 200 pounds, that’s somewhere between 42 and 45 pounds.
What the Head-to-Head Research Shows
A trial called SURMOUNT-5 put the two drugs side by side in adults with overweight or obesity who didn’t have diabetes. By week 72, with everyone titrated to their individual ceiling dose, the clinical split was obvious. Tirzepatide drove an average 20.2% weight loss, pushing about a third of participants past the 25% threshold. Semaglutide trailed at an average reduction of 13.7%, with roughly 16% shedding a quarter of their starting weight.
Averages smooth over a lot of individual differences. The trial was open-label, so everyone knew which pen they were using, and it excluded people with diabetes. Some people do far better on semaglutide than 13.7%. Others have a hard time tolerating tirzepatide.
Side effects led to more early dropouts in the semaglutide group. On the other hand, people taking tirzepatide ran into minor skin redness where they gave themselves the shot. Picking between them in real life isn’t just a matter of hunting down the biggest percentage on a study slide.
Side Effects and Safety
Both drugs slow digestion, so most of the side effects overlap:
- Nausea, often worst in the first few days after an injection
- Loose stools or constipation
- Vomiting now and then, or burps that taste like sulfur
- A bit of tiredness while your body gets used to eating less
We step your dose up slowly each month to give your body time to adapt. Small meals help during these first few weeks as you adjust. Eat small meals. Skip the greasy comfort food. Sip water throughout the day instead of waiting until you’re thirsty.
Both medications carry a boxed warning for thyroid C-cell tumors, which showed up in rodent studies. The FDA attaches a black box warning to both drugs because laboratory rats developed thyroid C-cell tumors during testing. Those with a health background of medullary thyroid carcinoma or MEN 2 need to pass on these entirely. Tell your clinician immediately if you are pregnant, have had gallstones, or have ever been in the hospital with pancreatitis.
How to Choose Between Semaglutide vs. Tirzepatide?
Your health history comes first. Heart disease, sleep apnea, and type 2 diabetes can all point toward one drug. Semaglutide has strong evidence for lowering the risk of cardiovascular events. Tirzepatide is approved for obstructive sleep apnea in adults with obesity.
Your stomach matters too. If it’s easily upset, the dose schedule counts for more than the drug. A slow climb through the doses is gentler than a fast one, whichever medication you take.
Cost and access are practical limits. Copays and deductibles swing wildly depending on your policy, and health plans drop or add prescription coverage with almost no advance notice. Ask about them early.
Then there are the needles. Both medications are injected at home with very small needles, and plenty of people still dislike the idea. That’s a normal reason to hesitate, so say so during your consultation. A weekly shot isn’t the only option anymore, since oral options are available. The point is to find a plan you can actually stick with.
What the First Few Months Looks Like
Treatment begins at the lowest dose available. About every four weeks, you and your provider check in on how things are going. If your body is handling the dose well, you can move up a step. If it isn’t, it holds where it is for a while.
Check-ins are crucial. Do not hide bad days from your clinician. Call your clinician if you start vomiting, get dry heaves during the workday, or hit a wall around 2:30. You shouldn’t push through any of that. Nausea is easier to prevent than to fix, so start the day with a couple of eggs, park a tall cup of water at your desk, and drink it down twice before dinner.
Some people land on a middle dose that fits. Appetite stays quiet, the weight comes down steadily, and side effects stay out of the picture. Stopping the climb at that point is a perfectly good decision. The aim was never the biggest number on the box. It’s the lowest dose that keeps you feeling well.
What’s Coming Next
The field is moving quickly. As of October 2026, this is where things stand.
“Pills are already here.”
The Wegovy pill, an oral form of semaglutide, was approved in December 2025. Lilly’s Foundayo, an oral medication called orforglipron, followed in April 2026. Foundayo can be taken at any time of day without food or water restrictions. In trials, the average weight loss at its highest dose was about 12% over 72 weeks, lower than that observed with injectable tirzepatide in separate trials. For some people, a daily pill is still the better fit than a weekly shot.
Retatrutide
Retatrutide adds a third hormone, glucagon, to the GIP and GLP-1 combination. It is still investigational. Lilly’s phase 3 trials have reported average weight loss of about 28% at the highest dose, but the drug is not approved. Lilly has said it plans to file with the FDA in the first quarter of 2027, so approval would follow. Be careful with any website or clinic selling retatrutide today. It is not an approved prescription medicine.
CagriSema
Novo Nordisk’s CagriSema pairs semaglutide with a second medicine called cagrilintide. Novo filed with the FDA in December 2025. It has not been approved yet, and a decision could come as late as this year.
Choosing a Clinic You Can Trust
When you search tirzepatide near me, you’ll find med spas, telehealth sites, and online pharmacies, and they are not all equal. A good clinic does four things the same way every time:
- Reviews every past medical record and current prescription before calling anything in.
- Outlines the weekly injection amounts, lists the side effects you might run into, and tells you what to do if stomach cramps or heartburn start.
- It follows up. Dose changes and check-ins are part of the plan, not an upsell.
- It is clear which medication you’re receiving and where it comes from.
At Solene, licensed clinicians offer both semaglutide and tirzepatide as part of medical weight loss, and we take our time with every visit. If you’re still sorting out semaglutide vs tirzepatide, that conversation is a good place to start.
There is no single best GLP-1 medication. There is one that fits your body, your health, and your life right now. If you’d like help finding it, whether you are searching for tirzepatide near me or still comparing options, schedule a consultation or contact us. We can go through a GLP-1 medication comparison built around you and answer questions about what’s next. For anything beyond semaglutide and tirzepatide, including other peptides, contact our office.